Mind Cure Health Inc. Announces $10 Million Bought Deal Public Offering Post published:January 21, 2021 Post category:Press Release
Mydecine Innovations Group Files Preliminary Prospectus in Connection with Bought Deal Offering of Units Post published:January 21, 2021 Post category:Press Release
North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF? Post published:January 21, 2021 Post category:Analysis/News
Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity Post published:January 21, 2021 Post category:Press Release
MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD Post published:January 20, 2021 Post category:Press Release
Tryp Therapeutics Invited to Present at “Investing in Psychedelics” Conference Post published:January 19, 2021 Post category:Press Release
Psyched Wellness Announces New OTCQB Ticker: PSYCF Post published:January 19, 2021 Post category:Press Release
BetterLife Confirms Non-controlled Status of 2-bromo-LSD with Health Canada Post published:January 19, 2021 Post category:Press Release
NeonMind Lists on the Frankfurt Stock Exchange Post published:January 19, 2021 Post category:Press Release